edotreotide has been researched along with Cancer of Liver in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, RP; Kulkarni, HR; Singh, A; Zhang, J | 1 |
| Baum, RP; Kulkarni, HR; Zhang, J | 1 |
| Davi', MV; Francia, G; Salgarello, M | 1 |
| Baete, K; Bogaerts, K; Clement, PM; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Nackaerts, K; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
| Freesmeyer, M; Knösel, T; Schulz, S; Settmacher, U | 1 |
| Baete, K; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
| Choyke, PL; Giesel, FL; Haberkorn, U; Haufe, S; Isermann, B; Kauczor, HU; Kratochwil, C; López-Benítez, R; Mier, W | 1 |
| Brenner, W; Hamm, B; Nogami, M; Pape, UF; Röttgen, R; Schreiter, NF; Steffen, I | 1 |
| Collins, DJ; d'Arcy, JA; Davidson, RL; Koh, DM; Koh, TS; Leach, MO; Lewington, V; Miyazaki, K; Orton, MR; Thng, CH | 1 |
| Bouterfa, H; Bushnell, D; Carlisle, T; Connolly, M; Karwal, M; Madsen, M; Menda, Y; O'Dorisio, T; Parker, S; Ponto, J; Ponto, L; Zehr, P | 1 |
| Angelini, C; Caprotti, R; Crippa, S; Mussi, C; Sartori, P; Uggeri, F | 1 |
| Börner, R; Henze, M; Heppeler, A; Hofmann, M; Knapp, H; Maecke, H; Meyer, J; Oei, L; Schöffski, P; Schumacher, J; Weckesser, E | 1 |
3 trial(s) available for edotreotide and Cancer of Liver
| Article | Year |
|---|---|
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases.
Topics: Adult; Aged; Chromogranin A; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases.
Topics: Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Aspartate Aminotransferases; Carcinoma, Neuroendocrine; Clinical Protocols; Disease Progression; Humans; Liver; Liver Neoplasms; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2003 |
9 other study(ies) available for edotreotide and Cancer of Liver
| Article | Year |
|---|---|
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor Antagonist.
Topics: Adult; Female; Humans; Liver Neoplasms; Lutetium; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radiopharmaceuticals | 2020 |
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide Therapy.
Topics: Actinium; Aged; Beta Particles; Disease Progression; Female; Humans; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Receptors, Peptide; Treatment Outcome | 2020 |
Positive (68)Ga-DOTATOC-PET/CT after cortisol level control during ketoconazole treatment in a patient with liver metastases from a pancreatic neuroendocrine tumor and ectopic Cushing syndrome.
Topics: Cushing Syndrome; Gallium Radioisotopes; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Imaging of somatostatin receptor subtype 2 in advanced hepatocellular carcinoma by 68Ga-DOTATOC PET.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Octreotide; Positron-Emission Tomography; Receptors, Somatostatin | 2009 |
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Topics: Adult; Disease Progression; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Somatostatin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.
Topics: Adult; Aged; Contrast Media; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Observer Variation; Octreotide; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Software | 2012 |
Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.
Topics: Adult; Aged; Area Under Curve; Contrast Media; Discriminant Analysis; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2012 |
Palliative management strategies of advanced gastrointestinal carcinoid neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Palliative Care; Radiopharmaceuticals; Yttrium | 2005 |
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.
Topics: Aged; Carcinoid Tumor; Female; Gallium Radioisotopes; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |